Cargando…
Friend leukemia virus integration 1 promotes tumorigenesis of small cell lung cancer cells by activating the miR-17-92 pathway
Small cell lung cancer (SCLC) is regarded as the most devastative type of human lung malignancies. The rapid and disseminated growth pattern remains the primary cause of poor clinical prognosis in patients with SCLC. However, the molecular factors that drive rapid progression of SCLC remain unclear....
Autores principales: | Li, Lingyu, Song, Wei, Yan, Xu, Li, Ailing, Zhang, Xiaoying, Li, Wei, Wen, Xue, Zhou, Lei, Yu, Dehai, Hu, Ji-Fan, Cui, Jiuwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522042/ https://www.ncbi.nlm.nih.gov/pubmed/28410216 http://dx.doi.org/10.18632/oncotarget.16715 |
Ejemplares similares
-
Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis
por: Xiang, Jie, et al.
Publicado: (2010) -
Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancer
por: Song, Wei, et al.
Publicado: (2015) -
Prognostic Value of the miR-17~92 Cluster in Chronic Lymphocytic Leukemia
por: Chocholska, Sylwia, et al.
Publicado: (2023) -
HNRNPA2B1 Affects the Prognosis of Esophageal Cancer by Regulating the miR-17-92 Cluster
por: Li, Kexin, et al.
Publicado: (2021) -
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
por: Sasaki, Kotaro, et al.
Publicado: (2010)